Loss of amyloid precursor protein exacerbates early inflammation in Niemann-Pick disease type C

[1]  M. Klein,et al.  Depletion of regulatory T cells increases T cell brain infiltration, reactive astrogliosis, and interferon-γ gene expression in acute experimental traumatic brain injury , 2019, Journal of Neuroinflammation.

[2]  Christopher G. Wilson,et al.  Interferon downstream signaling is activated early in pre-symptomatic Niemann-Pick disease type C , 2019, Neuroscience Letters.

[3]  Christopher G. Wilson,et al.  Cellular hormetic response to 27-hydroxycholesterol promotes neuroprotection through AICD induction of MAST4 abundance and kinase activity , 2017, Scientific Reports.

[4]  Fei Li,et al.  Erythropoietin regulates immune/inflammatory reaction and improves neurological function outcomes in traumatic brain injury , 2017, Brain and behavior.

[5]  A. Lucia,et al.  Niemann-Pick disease treatment: a systematic review of clinical trials. , 2015, Annals of translational medicine.

[6]  A. Suzumura,et al.  CCL11 enhances excitotoxic neuronal death by producing reactive oxygen species in microglia , 2015, Glia.

[7]  P. Das,et al.  Altered Innate Immune and Glial Cell Responses to Inflammatory Stimuli in Amyloid Precursor Protein Knockout Mice , 2015, PloS one.

[8]  C. Bocti,et al.  β-Amyloid peptides display protective activity against the human Alzheimer’s disease-associated herpes simplex virus-1 , 2015, Biogerontology.

[9]  C. Mackay.  CXCR3⁺CCR5⁺ T cells and autoimmune diseases: guilty as charged? , 2014, The Journal of clinical investigation.

[10]  Shweta Tripathi,et al.  Alzheimer's Associated β-Amyloid Protein Inhibits Influenza A Virus and Modulates Viral Interactions with Phagocytes , 2014, PloS one.

[11]  H. Lassmann,et al.  Expression of Ccl11 Associates with Immune Response Modulation and Protection against Neuroinflammation in Rats , 2012, PloS one.

[12]  Zhong-Hui Duan,et al.  Fold change and p-value cutoffs significantly alter microarray interpretations , 2012, BMC Bioinformatics.

[13]  J. Hibbert,et al.  CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications , 2011, Cytokine & growth factor reviews.

[14]  J. Cooper,et al.  Loss of amyloid precursor protein in a mouse model of Niemann–Pick type C disease exacerbates its phenotype and disrupts tau homeostasis , 2011, Neurobiology of Disease.

[15]  I. Campbell,et al.  Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity – a tale of conflict and conundrum , 2010, Neuropathology and applied neurobiology.

[16]  F. Platt,et al.  Lipids on Trial: The Search for the Offending Metabolite in Niemann‐Pick type C Disease , 2010, Traffic.

[17]  B. Hyman,et al.  The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide , 2010, PloS one.

[18]  B. Fischer,et al.  Abeta40, either soluble or aggregated, is a remarkably potent antioxidant in cell-free oxidative systems. , 2009, Biochemistry.

[19]  R. Sidman,et al.  TLR8: An Innate Immune Receptor in Brain, Neurons and Axons , 2007, Cell cycle.

[20]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Diamond,et al.  Neuronal CXCL10 Directs CD8+ T-Cell Recruitment and Control of West Nile Virus Encephalitis , 2005, Journal of Virology.

[22]  Colin L Masters,et al.  Gene knockout of amyloid precursor protein and amyloid precursor‐like protein‐2 increases cellular copper levels in primary mouse cortical neurons and embryonic fibroblasts , 2004, Journal of neurochemistry.

[23]  K. Schroder,et al.  Interferon- : an overview of signals, mechanisms and functions , 2004 .

[24]  Oreste Acuto,et al.  CD28-mediated co-stimulation: a quantitative support for TCR signalling , 2003, Nature Reviews Immunology.

[25]  M. Vanier.  Niemann-Pick disease type C , 2010, Orphanet journal of rare diseases.

[26]  J. Mudgett,et al.  Antibody‐mediated blockade of the CXCR3 chemokine receptor results in diminished recruitment of T helper 1 cells into sites of inflammation , 2003, Journal of leukocyte biology.

[27]  M. Kawaguchi,et al.  Differential regulation of eotaxin expression by IFN-γ in airway epithelial cells ☆ ☆☆ , 2003 .

[28]  K. Zou,et al.  A Novel Function of Monomeric Amyloid β-Protein Serving as an Antioxidant Molecule against Metal-Induced Oxidative Damage , 2002, The Journal of Neuroscience.

[29]  M. Dziejman,et al.  IFN-γ-Inducible Protein 10 (IP-10; CXCL10)-Deficient Mice Reveal a Role for IP-10 in Effector T Cell Generation and Trafficking1 , 2002, The Journal of Immunology.

[30]  J. Flier,et al.  Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation , 2001, The Journal of pathology.

[31]  M. Graeber,et al.  Neuronal MCP-1 Expression in Response to Remote Nerve Injury , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[32]  J. Farber.  Mig and IP‐10: CXC chemokines that target lymphocytes , 1997, Journal of leukocyte biology.

[33]  C. Bocti,et al.  Protective Effect of Amyloid-β Peptides Against Herpes Simplex Virus-1 Infection in a Neuronal Cell Culture Model. , 2016, Journal of Alzheimer's disease : JAD.

[34]  Martin Ingelsson,et al.  The Alzheimer's Disease-Associated Amyloid \(\beta\)-Protein Is an Antimicrobial Peptide , 2010 .

[35]  X. Bi,et al.  Cholesterol in Niemann-Pick Type C disease. , 2010, Sub-cellular biochemistry.

[36]  R. Ransohoff,et al.  Chemokine receptor CXCR3: an unexpected enigma. , 2005, Current topics in developmental biology.

[37]  K. Schroder,et al.  Interferon-gamma: an overview of signals, mechanisms and functions. , 2004, Journal of leukocyte biology.

[38]  M. Kawaguchi,et al.  Differential regulation of eotaxin expression by IFN-gamma in airway epithelial cells. , 2003, The Journal of allergy and clinical immunology.